Gateway Investment Advisers’s Moderna MRNA Stock Holding History

Gateway Investment Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$577K	Sell	8,235 -138,030	-94%	-$7.14M	0.01%	555
2026 Q1	$7.43M	Buy	146,265 +5,811	+4%	+$271K	0.08%	142
2025 Q4	$4.14M	Buy	140,454 +131,364	+1,445%	+$3.57M	0.04%	214
2025 Q3	$235K	Buy	+9,090	New	+$254K	﹤0.01%	504
2023 Q4	–	Sell	-58,445	Closed	-$6.04M	–	512
2023 Q3	$6.04M	Sell	58,445 -20,475	-26%	-$2.28M	0.08%	191
2023 Q2	$9.59M	Sell	78,920 -2,520	-3%	-$336K	0.11%	151
2023 Q1	$12.5M	Sell	81,440 -16,187	-17%	-$2.67M	0.15%	128
2022 Q4	$17.5M	Sell	97,627 -244	-0.2%	-$39.9K	0.22%	115
2022 Q3	$11.6M	Sell	97,871 -14,182	-13%	-$2.15M	0.14%	143
2022 Q2	$16M	Buy	112,053 +91,044	+433%	+$13M	0.18%	120
2022 Q1	$3.62M	Sell	21,009 -60,204	-74%	-$10.1M	0.04%	279
2021 Q4	$20.6M	Buy	81,213 +41,794	+106%	+$12.2M	0.2%	115
2021 Q3	$15.2M	Buy	+39,419	New	+$14.5M	0.16%	134

Other funds holding MRNA

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Gateway Investment Advisers's MRNA Position: Q2 2026 in Review

Gateway Investment Advisers reduced its Moderna (MRNA) stake by 94% in Q2 2026, selling an estimated $7.14M and leaving 8,235 shares worth $577K. The position accounts for 0.01% of the portfolio, ranked #555.

Gateway Investment Advisers first reported a position in MRNA in Q3 2021 and has held it in 13 quarters since. The position peaked at $20.6M in Q4 2021. 184 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Gateway Investment Advisers held 8,235 shares of Moderna worth $577K as of Q2 2026.
Gateway Investment Advisers sold 138,030 Moderna shares in Q2 2026, an estimated $7.14M.
Moderna made up 0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #555 holding.
Gateway Investment Advisers first reported a position in Moderna in Q3 2021 and has held it in 13 quarters since.
Gateway Investment Advisers's Moderna position peaked at $20.6M in Q4 2021.
184 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.